National Haemoglobinopathy Panel

University College London have produced a Standard Operating Procedure (SOP) for the assessment and work up of Exagamglogene Autotemcel (Casgevy™) for transfusion-dependent beta-thalassaemia in England. This document can be used as a template for other commissioned treatment centres. The SOP has been reviewed by the Haemoglobinopathies Clinical Reference Group, BMT Clinical Reference Group and the NHP Cellular Therapies Operational Group.